TERRI WEBBER MILLER: Open Payments
NPI 1376992818 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 69 payments from 14 companies in 2025. Trend: 2023 $1,092 · 2024 $1,060 · 2025 $1,438
Food & beverage: $1,242Education: $196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $234 |
| Amgen Inc. | 6 | $224 |
| Janssen Biotech, Inc. | 10 | $202 |
| GENZYME CORPORATION | 8 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $131 |
| Organon LLC | 9 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Lilly USA, LLC | 4 | $79 |
| Incyte Corporation | 3 | $66 |
| PFIZER INC. | 2 | $34 |
Products named: DUPIXENT, OTEZLA, TREMFYA, SKYRIZI, ILUMYA, RINVOQ, OPZELURA, TALTZ.
Industry payments across CO — which companies pay providers there.
